Clinical Trial Update: A Study to Evaluate the Immunogenicity and Safety of EV71 Vaccine in Pediatric Subjects [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the immunogenicity and safety of an EV71 vaccine in pediatric subjects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Enterovirus Infections

Drugs mentioned

• EV71 vaccine (enterovirus 71 vaccine)

Snippet

Sponsor: Enimmune Corporation | Conditions: Enterovirus Infections | Phase 2 | Status: COMPLETED